1-20 of 42
glycosylation end products, advanced
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Fast-Glycator Phenotype, Skin Advanced Glycation End Products, and Complication Burden Among People With Type 1 Diabetes

Alberto Maran, Mario Luca Morieri, Daniele Falaguasta, Angelo Avogaro, Gian Paolo Fadini
Journal: Diabetes Care
Diabetes Care 2022;45(10):2439–2444
https://doi.org/10.2337/dc22-0980
Published: 15 August 2022
View article titled, The Fast-Glycator Phenotype, Skin Advanced Glycation End Products, and Complication Burden Among People With Type 1 Diabetes
Open the PDF for The Fast-Glycator Phenotype, Skin Advanced Glycation End Products, and Complication Burden Among People With Type 1 Diabetes in another window
Journal Articles

Response to Comment on Koska et al. Advanced Glycation End Products Predict Loss of Renal Function and High-Risk Chronic Kidney Disease in Type 2 Diabetes. Diabetes Care 2022;44:684–691

Juraj Koska, Hertzel C. Gerstein, Paul J. Beisswenger, Peter D. Reaven
Journal: Diabetes Care
Diabetes Care 2022;45(6):e111–e112
https://doi.org/10.2337/dci22-0013
Published: 27 May 2022
View article titled, Response to Comment on Koska et al. Advanced Glycation End Products Predict Loss of Renal Function and High-Risk Chronic Kidney Disease in Type 2 Diabetes. Diabetes Care 2022;44:684–691
Open the PDF for Response to Comment on Koska et al. Advanced Glycation End Products Predict Loss of Renal Function and High-Risk Chronic Kidney Disease in Type 2 Diabetes. Diabetes Care 2022;44:684–691 in another window
Journal Articles

Comment on Koska et al. Advanced Glycation End Products Predict Loss of Renal Function and High-Risk Chronic Kidney Disease in Type 2 Diabetes. Diabetes Care 2022;44:684–691

Gauthier Borderie, Alice Larroumet, Laurence Baillet-Blanco, Ninon Foussard, Vincent Rigalleau
Journal: Diabetes Care
Diabetes Care 2022;45(6):e110
https://doi.org/10.2337/dc22-0337
Published: 27 May 2022
View article titled, Comment on Koska et al. Advanced Glycation End Products Predict Loss of Renal Function and High-Risk Chronic Kidney Disease in Type 2 Diabetes. Diabetes Care 2022;44:684–691
Open the PDF for Comment on Koska et al. Advanced Glycation End Products Predict Loss of Renal Function and High-Risk Chronic Kidney Disease in Type 2 Diabetes. Diabetes Care 2022;44:684–691 in another window
Journal Articles

Advanced Glycation End Products Predict Loss of Renal Function and High-Risk Chronic Kidney Disease in Type 2 Diabetes

Juraj Koska, Hertzel C. Gerstein, Paul J. Beisswenger, Peter D. Reaven
Journal: Diabetes Care
Diabetes Care 2022;45(3):684–691
https://doi.org/10.2337/dc21-2196
Published: 20 January 2022
View article titled, Advanced Glycation End Products Predict Loss of Renal Function and High-Risk Chronic Kidney Disease in Type 2 Diabetes
Open the PDF for Advanced Glycation End Products Predict Loss of Renal Function and High-Risk Chronic Kidney Disease in Type 2 Diabetes in another window
Journal Articles

Advanced Glycation End Products, Oxidation Products, and Incident Cardiovascular Events in Patients With Type 2 Diabetes

Juraj Koska, Aramesh Saremi, Scott Howell, Gideon Bahn, Barbora De Courten, Henry Ginsberg, Paul J. Beisswenger, Peter D. Reaven, for the VADT Investigators
Journal: Diabetes Care
Diabetes Care 2018;41(3):570–576
https://doi.org/10.2337/dc17-1740
Published: 05 December 2017
View article titled, Advanced Glycation End Products, Oxidation Products, and Incident Cardiovascular Events in Patients With Type 2 Diabetes
Open the PDF for Advanced Glycation End Products, Oxidation Products, and Incident Cardiovascular Events in Patients With Type 2 Diabetes in another window
Includes: Supplementary data
Journal Articles

Advanced Glycation End Products, Oxidation Products, and the Extent of Atherosclerosis During the VA Diabetes Trial and Follow-up Study

Aramesh Saremi, Scott Howell, Dawn C. Schwenke, Gideon Bahn, Paul J. Beisswenger, Peter D. Reaven, for the VADT Investigators
Journal: Diabetes Care
Diabetes Care 2017;40(4):591–598
https://doi.org/10.2337/dc16-1875
Published: 01 February 2017
View article titled, Advanced Glycation End Products, Oxidation Products, and the Extent of Atherosclerosis During the VA Diabetes Trial and Follow-up Study
Open the PDF for Advanced Glycation End Products, Oxidation Products, and the Extent of Atherosclerosis During the VA Diabetes Trial and Follow-up Study in another window
Includes: Supplementary data
Journal Articles

Relationship Between Levels of Advanced Glycation End Products and Their Soluble Receptor and Adverse Outcomes in Adults With Type 2 Diabetes

Merlin C. Thomas, Mark Woodward, Bruce Neal, Qiang Li, Raelene Pickering, Michel Marre, Bryan Williams, Vlado Perkovic, Mark E. Cooper, Sophia Zoungas, John Chalmers, Graham S. Hillis
Journal: Diabetes Care
Diabetes Care 2015;38(10):1891–1897
https://doi.org/10.2337/dc15-0925
Published: 07 August 2015
View article titled, Relationship Between Levels of Advanced Glycation End Products and Their Soluble Receptor and Adverse Outcomes in Adults With Type 2 Diabetes
Open the PDF for Relationship Between Levels of Advanced Glycation End Products and Their Soluble Receptor and Adverse Outcomes in Adults With Type 2 Diabetes in another window
Includes: Supplementary data
Journal Articles

Decrease in Circulating Concentrations of Soluble Receptors for Advanced Glycation End Products at the Time of Seroconversion to Autoantibody Positivity in Children With Prediabetes

Kirsi M. Salonen, Samppa J. Ryhänen, Josephine M. Forbes, Danielle J. Borg, Taina Härkönen, Jorma Ilonen, Olli Simell, Riitta Veijola, Per-Henrik Groop, Mikael Knip
Journal: Diabetes Care
Diabetes Care 2015;38(4):665–670
https://doi.org/10.2337/dc14-1186
Published: 08 January 2015
View article titled, Decrease in Circulating Concentrations of Soluble Receptors for Advanced Glycation End Products at the Time of Seroconversion to Autoantibody Positivity in Children With Prediabetes
Open the PDF for Decrease in Circulating Concentrations of Soluble Receptors for Advanced Glycation End Products at the Time of Seroconversion to Autoantibody Positivity in Children With Prediabetes in another window
Journal Articles

The Impact of Salsalate Treatment on Serum Levels of Advanced Glycation End Products in Type 2 Diabetes

Joshua I. Barzilay, Kathleen A. Jablonski, Vivian Fonseca, Steven E. Shoelson, Allison B. Goldfine, Christopher Strauch, Vincent M. Monnier, the TINSAL-T2D Research Consortium
Journal: Diabetes Care
Diabetes Care 2014;37(4):1083–1091
https://doi.org/10.2337/dc13-1527
Published: 08 March 2014
View article titled, The Impact of Salsalate Treatment on Serum Levels of Advanced Glycation End Products in Type 2 Diabetes
Open the PDF for The Impact of Salsalate Treatment on Serum Levels of Advanced Glycation End Products in Type 2 Diabetes in another window
Includes: Supplementary data
Journal Articles

Consumption of a Diet Low in Advanced Glycation End Products for 4 Weeks Improves Insulin Sensitivity in Overweight Women

Alicja Budek Mark, Malene Wibe Poulsen, Stine Andersen, Jeanette Marker Andersen, Monika Judyta Bak, Christian Ritz, Jens Juul Holst, John Nielsen, Barbora de Courten, Lars Ove Dragsted, Susanne Gjedsted Bügel
Journal: Diabetes Care
Diabetes Care 2014;37(1):88–95
https://doi.org/10.2337/dc13-0842
Published: 11 December 2013
View article titled, Consumption of a Diet Low in Advanced Glycation End Products for 4 Weeks Improves Insulin Sensitivity in Overweight Women
Open the PDF for Consumption of a Diet Low in Advanced Glycation End Products for 4 Weeks Improves Insulin Sensitivity in Overweight Women in another window
Includes: Supplementary data
Journal Articles

Early Progression of Diabetic Nephropathy Correlates With Methylglyoxal-Derived Advanced Glycation End Products

Paul J. Beisswenger, MD, Scott K. Howell, MS, Gregory B. Russell, MS, Michael E. Miller, PHD, Stephen S. Rich, PHD, Michael Mauer, MD
Journal: Diabetes Care
Diabetes Care 2013;36(10):3234–3239
https://doi.org/10.2337/dc12-2689
Published: 14 September 2013
View article titled, Early Progression of Diabetic Nephropathy Correlates With Methylglyoxal-Derived Advanced Glycation End Products
Open the PDF for Early Progression of Diabetic Nephropathy Correlates With Methylglyoxal-Derived Advanced Glycation End Products in another window
Journal Articles

Positive Association Between Serum Level of Glyceraldehyde-Derived Advanced Glycation End Products and Vascular Inflammation Evaluated by [18F]Fluorodeoxyglucose Positron Emission Tomography

Nobuhiro Tahara, MD, Sho-ichi Yamagishi, MD, Masayoshi Takeuchi, PHD, Akihiro Honda, MD, Atsuko Tahara, MD, Yoshikazu Nitta, MD, Norihiro Kodama, MD, Minori Mizoguchi, MD, Hayato Kaida, MD, Masatoshi Ishibashi, MD, Naofumi Hayabuchi, MD, Takanori Matsui, PHD, Tsutomu Imaizumi, MD
Journal: Diabetes Care
Diabetes Care 2012;35(12):2618–2625
https://doi.org/10.2337/dc12-0087
Published: 14 November 2012
View article titled, Positive Association Between Serum Level of Glyceraldehyde-Derived Advanced Glycation End Products and Vascular Inflammation Evaluated by [<sup>18</sup>F]Fluorodeoxyglucose Positron Emission Tomography
Open the PDF for Positive Association Between Serum Level of Glyceraldehyde-Derived Advanced Glycation End Products and Vascular Inflammation Evaluated by [<sup>18</sup>F]Fluorodeoxyglucose Positron Emission Tomography in another window
Includes: Supplementary data
Journal Articles

Serum Levels of Receptors for Advanced Glycation End Products in Normal-Weight and Obese Children Born Small and Large for Gestational Age

Valentina Chiavaroli, MD, Ebe D’Adamo, MD, Cosimo Giannini, MD, Tommaso de Giorgis, MD, Stefania De Marco, MD, Francesco Chiarelli, MD, Angelika Mohn, MD
Journal: Diabetes Care
Diabetes Care 2012;35(6):1361–1363
https://doi.org/10.2337/dc11-2302
Published: 11 May 2012
View article titled, Serum Levels of Receptors for Advanced Glycation End Products in Normal-Weight and Obese Children Born Small and Large for Gestational Age
Open the PDF for Serum Levels of Receptors for Advanced Glycation End Products in Normal-Weight and Obese Children Born Small and Large for Gestational Age in another window
Journal Articles

Advanced Glycation End Products in Children With Type 1 Diabetes: Family Matters?

Pascal Barat, MD, PHD, Benoît Cammas, MD, Aurélie Lacoste, MD, Jérôme Harambat, MD, Vanessa Vautier, MD, Fabienne Nacka, PHD, Jean-Benoît Corcuff, MD, PHD
Journal: Diabetes Care
Diabetes Care 2012;35(1):e1
https://doi.org/10.2337/dc11-1398
Published: 09 December 2011
View article titled, Advanced Glycation End Products in Children With Type 1 Diabetes: Family Matters?
Open the PDF for Advanced Glycation End Products in Children With Type 1 Diabetes: Family Matters? in another window
Journal Articles

Cardiovascular Complications in Diabetes: Targets and interventions

Alin O. Stirban, MD, Diethelm Tschoepe, MD
Journal: Diabetes Care
Diabetes Care 2008;31(Supplement_2):S215–S221
https://doi.org/10.2337/dc08-s257
Published: 01 February 2008
View article titled, Cardiovascular Complications in Diabetes: <subtitle>Targets and interventions</subtitle>
Open the PDF for Cardiovascular Complications in Diabetes: <subtitle>Targets and interventions</subtitle> in another window
Journal Articles

Macronutrients, Advanced Glycation End Products, and Vascular Reactivity

Paresh Dandona, MD, PHD, Ajay Chaudhuri, MD, Priya Mohanty, MD
Journal: Diabetes Care
Diabetes Care 2007;30(10):2750–2751
https://doi.org/10.2337/dc07-1323
Published: 01 October 2007
View article titled, Macronutrients, Advanced Glycation End Products, and Vascular Reactivity
Open the PDF for Macronutrients, Advanced Glycation End Products, and Vascular Reactivity in another window
Journal Articles

Single Oral Challenge by Advanced Glycation End Products Acutely Impairs Endothelial Function in Diabetic and Nondiabetic Subjects

Jaime Uribarri, MD, Alin Stirban, MD, Denise Sander, MS, Weijing Cai, MD, Monica Negrean, MS, Cristina E. Buenting, MS, Theodore Koschinsky, MD, Helen Vlassara, MD
Journal: Diabetes Care
Diabetes Care 2007;30(10):2579–2582
https://doi.org/10.2337/dc07-0320
Published: 01 October 2007
View article titled, Single Oral Challenge by Advanced Glycation End Products Acutely Impairs Endothelial Function in Diabetic and Nondiabetic Subjects
Open the PDF for Single Oral Challenge by Advanced Glycation End Products Acutely Impairs Endothelial Function in Diabetic and Nondiabetic Subjects in another window
Journal Articles

Noninvasive Type 2 Diabetes Screening: Superior sensitivity to fasting plasma glucose and A1C

John D. Maynard, MS, Mark Rohrscheib, MD, Jeffrey F. Way, BS, Catriona M. Nguyen, BSC, Marwood N. Ediger, PHD
Journal: Diabetes Care
Diabetes Care 2007;30(5):1120–1124
https://doi.org/10.2337/dc06-2377
Published: 01 May 2007
View article titled, Noninvasive Type 2 Diabetes Screening: <subtitle>Superior sensitivity to fasting plasma glucose and A1C</subtitle>
Open the PDF for Noninvasive Type 2 Diabetes Screening: <subtitle>Superior sensitivity to fasting plasma glucose and A1C</subtitle> in another window
Journal Articles

Advanced Glycation End Products and Antioxidant Status in Type 2 Diabetic Patients With and Without Peripheral Artery Disease

Annunziata Lapolla, MD, Francesco Piarulli, MD, Giovanni Sartore, MD, Antonio Ceriello, MD, Eugenio Ragazzi, MD, Rachele Reitano, MD, Lorenzo Baccarin, MLT, Barbara Laverda, MD, Domenico Fedele, MD
Journal: Diabetes Care
Diabetes Care 2007;30(3):670–676
https://doi.org/10.2337/dc06-1508
Published: 01 March 2007
View article titled, Advanced Glycation End Products and Antioxidant Status in Type 2 Diabetic Patients With and Without Peripheral Artery Disease
Open the PDF for Advanced Glycation End Products and Antioxidant Status in Type 2 Diabetic Patients With and Without Peripheral Artery Disease in another window
Journal Articles

Benfotiamine Prevents Macro- and Microvascular Endothelial Dysfunction and Oxidative Stress Following a Meal Rich in Advanced Glycation End Products in Individuals With Type 2 Diabetes

Alin Stirban, MD, Monica Negrean, MD, Bernd Stratmann, PHD, Thomas Gawlowski, MS, Tina Horstmann, Christian Götting, PHD, Knut Kleesiek, MD, Michaela Mueller-Roesel, MD, Theodor Koschinsky, MD, Jaime Uribarri, MD, Helen Vlassara, MD, Diethelm Tschoepe, MD
Journal: Diabetes Care
Diabetes Care 2006;29(9):2064–2071
https://doi.org/10.2337/dc06-0531
Published: 01 September 2006
View article titled, Benfotiamine Prevents Macro- and Microvascular Endothelial Dysfunction and Oxidative Stress Following a Meal Rich in Advanced Glycation End Products in Individuals With Type 2 Diabetes
Open the PDF for Benfotiamine Prevents Macro- and Microvascular Endothelial Dysfunction and Oxidative Stress Following a Meal Rich in Advanced Glycation End Products in Individuals With Type 2 Diabetes in another window